Ascentawits
About:
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.
Website: https://www.ascentawits.com
Top Investors: CICC, Cowin Capital, Shenzhen Guozhong Venture Capital Management, Sangel Capital, BGI Co-Win
Description:
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs. The company utilizes specific tumor micro-environments to carry out independent innovative drug designs and screening for the development of new anti-tumor drugs.
Total Funding Amount:
200M CNY
Headquarters Location:
Shenzhen, Guangdong, China
Founded Date:
2017-01-01
Founders:
Number of Employees:
51-100
Last Funding Date:
2021-02-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai